Amble vs Citizen Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Side-by-Side Comparison
| Feature | Amble | Citizen Meds |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.0/10 |
| Starting Price | $179/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | ✓3 features | 1 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Citizen Meds
Pros
- ✓Semaglutide confirmed from product listings
- ✓New patient discount available (NEWPATIENT10)
Cons
- ✗Pricing not publicly visible (JavaScript-rendered WooCommerce store)
- ✗No visible LegitScript or PCAB accreditation
- ✗State availability not disclosed
- ✗About page returns 404
- ✗Limited transparency — needs Chrome MCP verification for full product/pricing data
Our Verdict
Amble edges out Citizen Meds with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. Citizen Meds remains a solid alternative, especially if you're looking for pending full verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.